Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC

BSE9201.05111.35 (+1.23 %)

PREV CLOSE ( ) 9089.70

OPEN PRICE ( ) 9044.35

BID PRICE (QTY) 9183.95 (2)

OFFER PRICE (QTY) 9201.10 (6)

VOLUME 486

TODAY'S LOW / HIGH ( )8999.70 9246.65

52 WK LOW / HIGH ( )6222.35 10653.05

NSE9199.5086.5 (+0.95 %)

PREV CLOSE( ) 9113.00

OPEN PRICE ( ) 9075.00

BID PRICE (QTY) 9198.00 (1)

OFFER PRICE (QTY) 9205.50 (3)

VOLUME 5331

TODAY'S LOW / HIGH( ) 8994.00 9242.00

52 WK LOW / HIGH ( )6220 10691

Chairman	Shilpa Divekar Nirula
Company Secretary	Manasa R
Executive Director	Praveen Rao Akkinepally
Non Executive Director	Jesus Javier Diaz Ropero Esteso Sylvia Lorena Varela Ramon Hooi-Bien Chuah
Non Executive Independent Director	Revathy Ashok Monica Widhani
Whole Time Director	Bhavana Agrawal

Incorporation Year : 11-07 1979

Registered Office :

Address : Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring Road Bengaluru,
Karnataka-560045 .

Phone : 080 6774 8000

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE